Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30147% above fair value
$55.75−0.60 (-1.06%)
Close on Nov 20, 2026Market cap $3.33BP/E –Yield –
Axogen gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Axogen's gross profit for the twelve months ending Sep 30, 2026 was $198.00M, up 23.4% year over year. For fiscal 2025 it was $167.35M, up 17.9% from the year before. Over ten years it grew 22.2% a year on average. The highest annual figure on record is $167.35M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $167.35M | +17.9% |
| FY2024 | Dec 31, 2024 | $141.98M | +16.5% |
| FY2023 | Dec 31, 2023 | $121.87M | +12.0% |
| FY2022 | Dec 31, 2022 | $108.81M | +4.2% |
| FY2021 | Dec 31, 2021 | $104.43M | +15.1% |
| FY2020 | Dec 31, 2020 | $90.72M | +1.5% |
| FY2019 | Dec 31, 2019 | $89.36M | +25.8% |
| FY2018 | Dec 31, 2018 | $71.01M | +38.9% |
| FY2017 | Dec 31, 2017 | $51.12M | +47.6% |
| FY2016 | Dec 31, 2016 | $34.64M | +54.1% |
| FY2015 | Dec 31, 2015 | $22.48M | +68.1% |
| FY2014 | Dec 31, 2014 | $13.38M | +57.2% |
| FY2013 | Dec 31, 2013 | $8.51M | +48.5% |
| FY2012 | Dec 31, 2012 | $5.73M | +136.5% |
| FY2011 | Dec 31, 2011 | $2.42M | +49.1% |
| FY2010 | Dec 31, 2010 | $1.63M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $56.73M | +23.3% |
| Q2 FY2026 | Jun 30, 2026 | $50.67M | +20.6% |
| Q1 FY2026 | Mar 31, 2026 | $46.19M | +32.2% |
| Q4 FY2025 | Dec 31, 2025 | $44.41M | +18.2% |
| Q3 FY2025 | Sep 30, 2025 | $45.99M | +26.2% |
| Q2 FY2025 | Jun 30, 2025 | $42.02M | +18.9% |
| Q1 FY2025 | Mar 31, 2025 | $34.93M | +7.1% |
| Q4 FY2024 | Dec 31, 2024 | $37.58M | +17.3% |
| Q3 FY2024 | Sep 30, 2024 | $36.44M | +14.9% |
| Q2 FY2024 | Jun 30, 2024 | $35.35M | +19.2% |
| Q1 FY2024 | Mar 31, 2024 | $32.62M | +14.5% |
| Q4 FY2023 | Dec 31, 2023 | $32.02M | +31.3% |
| Q3 FY2023 | Sep 30, 2023 | $31.70M | +3.0% |
| Q2 FY2023 | Jun 30, 2023 | $29.65M | +5.3% |
| Q1 FY2023 | Mar 31, 2023 | $28.49M | +11.9% |
| Q4 FY2022 | Dec 31, 2022 | $24.40M | -6.6% |
| Q3 FY2022 | Sep 30, 2022 | $30.78M | +18.6% |
| Q2 FY2022 | Jun 30, 2022 | $28.17M | +6.4% |
| Q1 FY2022 | Mar 31, 2022 | $25.46M | -1.6% |
| Q4 FY2021 | Dec 31, 2021 | $26.11M | -3.4% |
| Q3 FY2021 | Sep 30, 2021 | $25.97M | -6.4% |
| Q2 FY2021 | Jun 30, 2021 | $26.49M | +60.4% |
| Q1 FY2021 | Mar 31, 2021 | $25.87M | +33.0% |
| Q4 FY2020 | Dec 31, 2020 | $27.03M | +16.1% |
| Q3 FY2020 | Sep 30, 2020 | $27.73M | +15.3% |
| Q2 FY2020 | Jun 30, 2020 | $16.51M | -26.5% |
| Q1 FY2020 | Mar 31, 2020 | $19.45M | -0.6% |
| Q4 FY2019 | Dec 31, 2019 | $23.28M | +17.6% |
| Q3 FY2019 | Sep 30, 2019 | $24.05M | +25.3% |
| Q2 FY2019 | Jun 30, 2019 | $22.46M | +28.5% |
| Q1 FY2019 | Mar 31, 2019 | $19.57M | +34.5% |
| Q4 FY2018 | Dec 31, 2018 | $19.79M | +37.9% |
| Q3 FY2018 | Sep 30, 2018 | $19.20M | +41.8% |
| Q2 FY2018 | Jun 30, 2018 | $17.48M | +35.6% |
| Q1 FY2018 | Mar 31, 2018 | $14.55M | +40.9% |
| Q4 FY2017 | Dec 31, 2017 | $14.36M | +49.9% |
| Q3 FY2017 | Sep 30, 2017 | $13.54M | – |
| Q2 FY2017 | Jun 30, 2017 | $12.89M | – |
| Q1 FY2017 | Mar 31, 2017 | $10.33M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.58M | – |
See a number that looks wrong?